Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver

Drug Metabolism and Disposition

Volumn 36, Issue 12, 2008, Pages 2499-2505

  Celius, Trine ^a   Roblin, Steven ^a,b   Harper, Patricia A ^a,b   Matthews, Jason ^a   Boutros, Paul C ^a   Pohjanvirta, Raimo ^c,d   Okey, Allan B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; DIMETHYLANILINE MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; LIVER; LIVER MICROSOME; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TRANSGENIC MOUSE; WILD TYPE; XENOBIOTIC METABOLISM;

ANIMAL STRUCTURES; ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CYTOCHROME P-450 CYP1A1; DNA; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; ISOENZYMES; LIVER; MALE; METHIMAZOLE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSOMES, LIVER; OXYGENASES; PROTEIN BINDING; RATS; RECEPTORS, ARYL HYDROCARBON; SEX CHARACTERISTICS; TETRACHLORODIBENZODIOXIN;

MUS; MUS MUSCULUS; RATTUS;

EID: 57349112339     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023457     Document Type: Article

References (35)

1. Boutros PC, Yan R, Pohjanvirta R, and Okey AB (2008) Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics 9:419.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Cashman JR and Zhang J (2006) Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 46:65-100.
4. Chen JJ, Chen GS, and Bunce NJ (2003) Inhibition of CYP 1A2-dependent MROD activity in rat liver microsomes: an explanation of the hepatic sequestration of a limited subset of halogenated aromatic hydrocarbons. Environ Toxicol 18:115-119.
5. Cherrington NJ, Cao Y, Cherrington JW, Rose RL, and Hodgson E (1998) Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5. Xenobiotica 28:673-682.
6. 4-steroid 5α-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450. J Biol Chem 261:10728-10735.
7. Diliberto JJ, Burgin D, and Birnbaum LS (1997) Role of CYP1A2 in hepatic sequestration of dioxin: studies using CYP1A2 knock-out mice. Biochem Biophys Res Commun 236:431-433.
8. Dixit A and Roche TE (1984) Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Arch Biochem Biophys 233:50-63.
9. Dolphin CT, Janmohamed A, Smith RL, Shephard EA, and Phillips IR (1997) Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet 17:491-494.
10. Falls JG, Ryu DY, Cao Y, Levi PE, and Hodgson E (1997) Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 342:212-223.
11. Fu C, Xi L, Wu Y, McCarter R, Richardson A, Hickey M, and Han ES (2004) Hepatic genes altered in expression by food restriction are not influenced by the low plasma glucose level in young male GLUT4 transgenic mice. J Nutr 134:2965-2974.
12. Hankinson O (2005) Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys 433:379-386.
13. Hernandez D, Janmohamed A, Chandan P, Phillips IR, and Shephard EA (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 14:117-130.
14. Hines RN (2006) Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3. Expert Opin Drug Metab Toxicol 2:41-49.
15. Janmohamed A, Hernandez D, Phillips IR, and Shephard EA (2004) Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem Pharmacol 68:73-83.
16. Kent WJ (2002) BLAT - the BLAST-like alignment tool. Genome Res 12:656-664.
17. Klick DE, Shadley JD, and Hines RN (2008) Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein β (C/EBPβ) liver inhibitory and liver activating proteins. Biochem Pharmacol 76:268-278.
18. Krueger SK and Williams DE (2005) Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106:357-387.
19. Luo Z and Hines RN (2001) Regulation of flavin-containing monooxygenase 1 expression by ying yang 1 and hepatic nuclear factors 1 and 4. Mol Pharmacol 60:1421-1430.
20. Matthews J, Wihlén B, Thomsen J, and Gustafsson JA (2005) Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor α to 2,3,7,8-tetrachlorodibenzo-p-dioxin- responsive promoters. Mol Cell Biol 25:5317-5328.
21. Moffat ID, Boutros PC, Celius T, Lindén J, Pohjanvirta R, and Okey AB (2007a) microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol Sci 99:470-487.
22. Moffat ID, Roblin S, Harper PA, Okey AB, and Pohjanvirta R (2007b) Aryl hydrocarbon receptor splice variants in the dioxin-resistant rat: tissue expression and transactivational activity. Mol Pharmacol 72:956-966.
23. Motika MS, Zhang J, and Cashman JR (2007) Flavin-containing monooxygenase 3 and human disease. Expert Opin Drug Metab Toxicol 3:831-845.
24. Okey AB (2007) An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicol Sci 98:5-38.
25. Patel RD, Hollingshead BD, Omiecinski CJ, and Perdew GH (2007) Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Hepatology 46:209-218.
26. Phillips IR, Francois AA, and Shephard EA (2007) The flavin-containing monooxygenases (FMOs): genetic variation and its consequences for the metabolism of therapeutic drugs. Curr Pharmacogenomics 5:292-313.
27. Pohjanvirta R and Tuomisto J (1994) Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev 46:483-549.
28. Rozen S, Skaletsky H (2000) Primer3 on the WWW for General Users and for Biologist Programmers. Humana Press, Totawa, NJ.
29. Siddens LK, Henderson MC, Vandyke JE, Williams DE, and Krueger SK (2008) Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms. Biochem Pharmacol 75:570-579.
30. Staskal D, Diliberto J, Devito M, and Birnbaum L (2005) Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84:225-231.
31. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, and Pohjanvirta R (2006) The aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69:140-153.
32. Treacy EP, Akerman BR, Chow LM, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, et al. (1998) Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet 7:839-845.
33. Yeung CK, Adman ET, and Rettie AE (2007) Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria. Arch Biochem Biophys 464:251-259.
34. Yeung CK and Rettie AE (2006) Prochiral sulfoxidation as a probe for flavin-containing monooxygenases. Methods Mol Biol 320:163-172.
35. Zhang J, Cerny MA, Lawson M, Mosadeghi R, and Cashman JR (2007) Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5. J Biochem Mol Toxicol 21:206-215.